NASDAQ
Inovio Pharmaceuticals, Inc. (INO) has a price/fcf ratio of -9.18x as of Monday, May 25, 2026. This represents a 41.30% increase compared to its 12-month average of -15.63x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.